Department of Pathology, Qingdao Municipal Hospital, Qingdao, China.
Department of Urology, Qingdao Municipal Hospital, Qingdao, China.
Pathol Oncol Res. 2023 Nov 28;29:1611343. doi: 10.3389/pore.2023.1611343. eCollection 2023.
Squamous differentiation of prostate cancer, which accounts for less than 1% of all cases, is typically associated with androgen deprivation treatment (ADT) or radiotherapy. This entity is aggressive and exhibits poor prognosis due to limited response to traditional treatment. However, the underlying molecular mechanisms and etiology are not fully understood. Previous findings suggest that squamous cell differentiation may potentially arise from prostate adenocarcinoma (AC), but further validation is required to confirm this hypothesis. This paper presents a case of advanced prostate cancer with a combined histologic pattern, including keratinizing SCC and AC. The study utilized whole-exome sequencing (WES) data to analyze both subtypes and identified a significant overlap in driver gene mutations between them. This suggests that the two components shared a common origin of clones. These findings emphasize the importance of personalized clinical management for prostate SCC, and specific molecular findings can help optimize treatment strategies.
前列腺癌的鳞状分化占所有病例的比例不到 1%,通常与雄激素剥夺治疗 (ADT) 或放射治疗有关。这种肿瘤具有侵袭性,预后不良,因为对传统治疗的反应有限。然而,其潜在的分子机制和病因尚不完全清楚。先前的研究结果表明,鳞状细胞分化可能潜在地源于前列腺腺癌 (AC),但需要进一步验证来确认这一假说。本文报告了一例具有混合组织学模式的晚期前列腺癌,包括角化性 SCC 和 AC。该研究利用全外显子组测序 (WES) 数据对这两个亚型进行了分析,发现它们的驱动基因突变有显著重叠。这表明这两个成分的克隆具有共同的起源。这些发现强调了为前列腺 SCC 进行个性化临床管理的重要性,并且特定的分子发现可以帮助优化治疗策略。